ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Investors in ArcticZymes Technologies ASA (OB:AZT) had a good week, as its shares rose 3.1% to close at kr20.10 following the release of its second-quarter results. It looks like the results were a bit of a negative overall. While revenues of kr34m were in line with analyst predictions, statutory earnings were less than expected, missing estimates by 9.0% to hit kr0.10 per share. This is an important time for investors, as they can track a company's performance in its report, look at what expert is forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimate suggests is in store for next year.
Taking into account the latest results, the consensus forecast from ArcticZymes Technologies' one analyst is for revenues of kr140.0m in 2026. This reflects a reasonable 4.9% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to increase 2.8% to kr0.31. In the lead-up to this report, the analyst had been modelling revenues of kr139.9m and earnings per share (EPS) of kr0.32 in 2026. The analyst seem to have become a little more negative on the business after the latest results, given the minor downgrade to their earnings per share numbers for next year.
See our latest analysis for ArcticZymes Technologies
The average price target fell 13% to kr28.00, with reduced earnings forecasts clearly tied to a lower valuation estimate.
Of course, another way to look at these forecasts is to place them into context against the industry itself. For example, we noticed that ArcticZymes Technologies' rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 10% growth to the end of 2026 on an annualised basis. That is well above its historical decline of 2.4% a year over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 16% annually for the foreseeable future. So although ArcticZymes Technologies' revenue growth is expected to improve, it is still expected to grow slower than the industry.
The Bottom Line
The most important thing to take away is that the analyst downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. Furthermore, the analyst also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have analyst estimates for ArcticZymes Technologies going out as far as 2028, and you can see them free on our platform here.
You can also see our analysis of ArcticZymes Technologies' Board and CEO remuneration and experience, and whether company insiders have been buying stock.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.